ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
칼시필락시스 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 8.5%의 CAGR로 28억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 성장의 배경에는 헬스케어 지출 증가, 협업 및 파트너십 증가, 개인화된 의료에 대한 관심, 규제 당국의 지원 및 신속한 승인, 환자 중심의 헬스케어 접근 방식이 있습니다. 예측 기간 동안 주요 동향으로는 새로운 치료법, 진단의 발전, R&D 증가, 공동 이니셔티브, 환자 중심 접근법, 규제 환경의 역학 등이 있습니다.
신장 질환 유병률의 증가는 칼시필락시스 치료 시장의 성장을 견인할 것으로 예상됩니다. 신장 질환은 노폐물과 과도한 수분을 걸러내는 중요한 기능에 영향을 미치고 칼슘과 인산 대사를 억제하여 석회 침착증의 위험을 증가시키며, 2023년 영국의 만성 신장 질환 환자 수는 719만 명으로 추정되며, 인구의 10% 이상을 차지하고 2033년에는 761만 명에 달할 것으로 예상됩니다. 신장 질환의 유병률 증가는 칼시필락시스 치료 시장의 주요 촉진요인이 될 것입니다.
현재 진행 중인 임상시험의 확대는 칼시필락시스 치료 시장을 더욱 촉진할 것으로 예상됩니다. 임상시험은 잠재적 치료법의 안전성과 유효성을 평가하는 데 매우 중요한 역할을 하며, 치료 접근법을 개선하는 데 도움이 되는 귀중한 증거를 제공합니다. 전 세계 임상시험 등록 건수는 2022년 437,523건에서 2023년 468,457건으로 증가했으며, 진행 중인 임상시험은 칼시필락시스에 대한 의학적 이해와 치료에 필수적인 인사이트와 진전을 가져와 시장 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 칼시필락시스 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 칼시필락시스 치료 시장 : 성장률 분석
세계의 칼시필락시스 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 칼시필락시스 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 칼시필락시스 치료 전체 시장(TAM)
제6장 시장 세분화
세계의 칼시필락시스 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
고압산소요법
기타 유형
세계의 칼시필락시스 치료 시장 : 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
이미징
혈액 검사
심부 피부 생검
세계의 칼시필락시스 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
의료 연구 센터
학술기관
세계의 칼시필락시스 치료 시장, 의약품 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
티오황산나트륨
비스포스포네이트
시나칼셋
부갑상선호르몬
고압산소요법
세계의 칼시필락시스 치료 시장, 고압산소요법 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 장소 고압산소요법
다중 장소 고압산소요법
세계의 칼시필락시스 치료 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
투석
상처 치료와 관리
외과적 개입
제7장 지역별·국가별 분석
세계의 칼시필락시스 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 칼시필락시스 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
칼시필락시스 치료 시장 : 경쟁 구도
칼시필락시스 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
AstraZeneca Plc
Sanofi SA
3M Company
GlaxoSmithKline Plc
Eli Lilly and Company
Amgen Inc.
Boehringer Ingelheim
Novo Nordisk
Viatris(Mylan N.V.)
Regeneron Pharmaceuticals Inc.
Smith And Nephew Plc.
Incyte Corporation
ConvaTec Inc.
Vifor Pharma Group
BSN Medical GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
칼시필락시스 치료 시장 2029 : 새로운 기회를 제공하는 국가
칼시필락시스 치료 시장 2029 : 새로운 기회를 제공하는 부문
칼시필락시스 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare and severe medical condition characterized by the deposition of calcium in small blood vessels and tissues. It primarily affects individuals with kidney disease, especially those with end-stage renal disease (ESRD). The treatment approach involves pain management and nutritional support therapies to address symptoms such as painful and non-healing skin ulcers, tissue necrosis, and potential complications such as sepsis, which can pose life-threatening risks.
The main types of calciphylaxis treatment include medication, hyperbaric oxygen therapy, and other interventions. Medication involves the use of pharmaceutical drugs to manage symptoms and underlying causes. Medications such as sodium thiosulfate, opioids, or non-opioid drugs may be employed to treat or prevent infections, manage pain, and address aspects associated with calciphylaxis. Diagnosis is typically carried out through imaging, blood tests, and deep skin biopsies performed by end users such as hospitals, clinics, medical research centers, and academic institutes.
The calciphylaxis treatment market research report is one of a series of new reports from The Business Research Company that provides calciphylaxis treatment market statistics, including calciphylaxis treatment industry global market size, regional shares, competitors with an calciphylaxis treatment market share, detailed calciphylaxis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the calciphylaxis treatment industry. This calciphylaxis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The calciphylaxis treatment market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing incidence of calciphylaxis, rising awareness among healthcare professionals, expanding healthcare infrastructure, clinical research and drug development.
The calciphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, increasing collaboration and partnerships, focus on personalized medicine, regulatory support and expedited approvals, patient-centric healthcare approaches. Major trends in the forecast period include emerging therapeutic modalities, diagnostic advancements, increased research and development, collaborative initiatives, patient-centric approaches, regulatory landscape dynamics.
The anticipated rise in the prevalence of kidney diseases is set to drive the growth of the calciphylaxis treatment market. Kidney diseases, affecting the vital function of filtering waste products and excess fluids, disrupt calcium and phosphate metabolism, increasing the risk of calciphylaxis. With an estimated 7.19 million people affected by chronic kidney disease in the UK in 2023, representing over 10% of the population and expected to reach 7.61 million by 2033, the growing prevalence of kidney diseases will be a key driver for the calciphylaxis treatment market.
The expansion of ongoing clinical trials is expected to further boost the calciphylaxis treatment market. Clinical trials play a pivotal role in assessing the safety and efficacy of potential treatments, contributing valuable evidence for improved therapeutic approaches. With the number of registered studies increasing from 437,523 in 2022 to 468,457 in 2023 globally, the ongoing clinical trials provide essential insights and advancements in the medical understanding and treatment of calciphylaxis, contributing to the market's growth.
Leading companies in the calciphylaxis treatment market are focusing on developing advanced diagnostic techniques and health evaluation services to enhance profitability. By introducing comprehensive in-home kidney health evaluations, companies such as Signify Health, Inc. aim to provide convenient and proactive monitoring solutions for kidney health. Such initiatives, including urinalysis and estimated glomerular filtration rate assessments, prove valuable in early detection and management of chronic kidney health issues, including conditions such as calciphylaxis.
In January 2024, Merck KGaA, a Germany-based science and technology company providing calciphylaxis treatment, partnered with Inspirna Inc. Through this partnership, Merck KGaA expanded its colorectal cancer portfolio via a licensing agreement for the drug ompenaclid (RGX-202). This first-in-class oral inhibitor targets the creatine transport channel SLC6A8 and is currently in Phase II development for advanced RAS-mutated colorectal cancer (mCRC). Inspirna Inc. is a U.S.-based clinical-stage biopharmaceutical company.
Major companies operating in the calciphylaxis treatment market report are Pfizer Inc., Merck And Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, 3M Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Novo Nordisk, Viatris (Mylan N.V.), Regeneron Pharmaceuticals Inc., Smith And Nephew Plc., Incyte Corporation, ConvaTec Inc., Vifor Pharma Group, BSN Medical GmbH, Panion And BF Biotech Inc., Inozyme Pharma Inc., Sanifit Therapeutics S.A, Hope Pharmaceuticals, Menlo Therapeutics
North America was the largest region in the calciphylaxis treatment market in 2024 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the calciphylaxis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The calciphylaxis treatment market consists of revenues earned by entities by providing diagnostic services such as infrared thermography, electrolyte and mineral analysis, and measuring serum parathyroid hormone (PTH) levels to diagnose and assess the severity of calciphylaxis in patients. The market value includes the value of related goods sold by the service provider or included within the service offering. The calciphylaxis treatment market also includes sales of intensive wound care, clot-dissolving therapy, and vitamin K therapy, which are comprehensive treatment approaches for managing calciphylaxis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Calciphylaxis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on calciphylaxis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for calciphylaxis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The calciphylaxis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Medication; Hyperbaric Oxygen Therapy; Other Types
2) By Diagnosis: Imaging; Blood Tests; Deep Skin Biopsies
3) By End User: Hospitals; Clinics; Medical Research Centers; Academic Institutes
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Calciphylaxis Treatment Market Characteristics
3. Calciphylaxis Treatment Market Trends And Strategies
4. Calciphylaxis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Calciphylaxis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Calciphylaxis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Calciphylaxis Treatment Market Growth Rate Analysis
5.4. Global Calciphylaxis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Calciphylaxis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Calciphylaxis Treatment Total Addressable Market (TAM)
6. Calciphylaxis Treatment Market Segmentation
6.1. Global Calciphylaxis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Hyperbaric Oxygen Therapy
Other Types
6.2. Global Calciphylaxis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging
Blood Tests
Deep Skin Biopsies
6.3. Global Calciphylaxis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Medical Research Centers
Academic Institutes
6.4. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sodium Thiosulfate
Bisphosphonates
Cinacalcet
Parathyroid Hormone
Hyperbaric Oxygen Therapy
6.5. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Hyperbaric Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoplace Hyperbaric Oxygen Therapy
Multiplace Hyperbaric Oxygen Therapy
6.6. Global Calciphylaxis Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dialysis
Wound Care And Management
Surgical Interventions
7. Calciphylaxis Treatment Market Regional And Country Analysis
7.1. Global Calciphylaxis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Calciphylaxis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
